ACHE and early-onset autosomal dominant Alzheimer disease: Considering their pharmacological importance as a promising strategy, acetylcholinesterase (AChE) inhibitors are used mainly for the treatment of neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, senile dementia (involving cognitive decline), ataxia, and myasthenia gravis.